We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 10,000 results
  1. Depleting profibrotic macrophages using bioactivated in vivo assembly peptides ameliorates kidney fibrosis

    Managing renal fibrosis is challenging owing to the complex cell signaling redundancy in diseased kidneys. Renal fibrosis involves an immune response...

    Qing Ouyang, Chao Wang, ... **angmei Chen in Cellular & Molecular Immunology
    Article 13 June 2024
  2. ELABELA-derived peptide ELA13 attenuates kidney fibrosis by inhibiting the Smad and ERK signaling pathways

    Kidney fibrosis is an inevitable result of various chronic kidney diseases (CKDs) and significantly contributes to end-stage renal failure....

    Zhibin Yan, Ying Shi, ... Caiyun Fu in Journal of Zhejiang University-SCIENCE B
    Article 13 April 2024
  3. Targeting the m6A RNA methyltransferase METTL3 attenuates the development of kidney fibrosis

    Kidney fibrosis is a major mechanism underlying chronic kidney disease (CKD). N 6 -methyladenosine (m 6 A) RNA methylation is associated with organ...

    Hae Rim Jung, Jeonghwan Lee, ... Sung-Yup Cho in Experimental & Molecular Medicine
    Article Open access 01 February 2024
  4. OTUD1 promotes hypertensive kidney fibrosis and injury by deubiquitinating CDK9 in renal epithelial cells

    Hypertensive renal disease (HRD) contributes to the progression of kidney dysfunction and ultimately leads to end-stage renal disease. Understanding...

    Meng-yang Wang, Tian-xiang Yu, ... Guang Liang in Acta Pharmacologica Sinica
    Article 18 December 2023
  5. Targeted VEGFA therapy in regulating early acute kidney injury and late fibrosis

    Damage to peritubular capillaries is a key process that contributes to acute kidney injury (AKI) progression. Vascular endothelial growth factor A...

    Meng-jie Huang, Yu-wei Ji, ... Zhe Feng in Acta Pharmacologica Sinica
    Article 13 April 2023
  6. Fisetin treatment alleviates kidney injury in mice with diabetes-exacerbated atherosclerosis through inhibiting CD36/fibrosis pathway

    Diabetes-related vascular complications include diabetic cardiovascular diseases (CVD), diabetic nephropathy (DN) and diabetic retinopathy, etc. DN...

    Ting-feng Zou, Zhi-gang Liu, ... **ao-xiao Yang in Acta Pharmacologica Sinica
    Article 24 May 2023
  7. Identification and Functional Mechanism Verification of Novel MicroRNAs Associated with the Fibrosis Progression in Chronic Kidney Disease

    Chronic kidney disease (CKD) is a serious threat to human health worldwide, and its incidence is increasing annually. A growing amount of...

    Kaiying He, **aochun Zhou, ... Jianqin Wang in Biochemical Genetics
    Article Open access 05 February 2024
  8. Nrf2 knockout attenuates the astragaloside IV therapeutic effect on kidney fibrosis from liver cancer by regulating pSmad3C/3L pathways

    Fibrotic kidney injury from hepatocarcinogenesis seriously impacts treatment effect. Astragaloside IV (AS-IV), an extract of Astragalus membranaceus,...

    Qin Wang, Jiacheng Xu, ... Yan Yang in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 15 September 2023
  9. Single-cell analysis identifies the interaction of altered renal tubules with basophils orchestrating kidney fibrosis

    Inflammation is an important component of fibrosis but immune processes that orchestrate kidney fibrosis are not well understood. Here we apply...

    Tomohito Doke, Amin Abedini, ... Katalin Susztak in Nature Immunology
    Article 12 May 2022
  10. Alpha lipoamide inhibits diabetic kidney fibrosis via improving mitochondrial function and regulating RXRα expression and activation

    Previous studies have shown mitochondrial dysfunction in various acute kidney injuries and chronic kidney diseases. Lipoic acid exerts potent effects...

    Hui-fang Zhang, Hui-ming Liu, ... Yuan-yuan Wang in Acta Pharmacologica Sinica
    Article 08 November 2022
  11. Kidney-specific methylation patterns correlate with kidney function and are lost upon kidney disease progression

    Background

    Chronological and biological age correlate with DNA methylation levels at specific sites in the genome. Linear combinations of multiple...

    Naor Sagy, Noa Meyrom, ... Daniel Z. Bar in Clinical Epigenetics
    Article Open access 12 February 2024
  12. Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)-Targeted Therapeutics for Cystic Fibrosis

    Treatment of the common life-limiting genetic disease cystic fibrosis (CF) has been transformed by small molecule therapeutics that target the root...
    Diana-Florentina Veselu, Han-I Yeh, ... David N. Sheppard in Ion Channels as Targets in Drug Discovery
    Chapter 2024
  13. Exosomes From Human Umbilical Cord Stem Cells Suppress Macrophage-to-myofibroblast Transition, Alleviating Renal Fibrosis

    Renal fibrosis, a progressive scarring of the kidney, lacks effective treatment. Human umbilical cord mesenchymal stem cell-derived exosomes...

    Qitong Guo, ** Li, ... Deying Zhang in Inflammation
    Article 25 April 2024
  14. NFAT inhibitor 11R-VIVIT ameliorates mouse renal fibrosis after ischemia-reperfusion-induced acute kidney injury

    Acute kidney injury (AKI) with maladaptive tubular repair leads to renal fibrosis and progresses to chronic kidney disease (CKD). At present, there...

    Zhi-yong **e, Wei Dong, ... **n-ling Liang in Acta Pharmacologica Sinica
    Article Open access 22 December 2021
  15. The programming of kidney injury in offspring affected by maternal overweight and obesity: role of lipid accumulation, inflammation, oxidative stress, and fibrosis in the kidneys of offspring

    Maternal overweight and obesity are considered important factors affecting fetal development with many potential consequences for offspring after...

    Nichakorn Phengpol, Laongdao Thongnak, Anusorn Lungkaphin in Journal of Physiology and Biochemistry
    Article 20 October 2022
  16. Integrative informatics analysis identifies that ginsenoside Re improves renal fibrosis through regulation of autophagy

    We previously demonstrated that ginsenoside Re (G-Re) has protective effects on acute kidney injury. However, the underlying mechanism is still...

    Yingying Liu, Lingyun Mou, ... **aoxia Yu in Journal of Natural Medicines
    Article 29 April 2024
  17. Idiopathic Pulmonary Fibrosis

    The unknown aetiology of irreversible fibrotic scarring of lung tissues in Idiopathic Pulmonary Fibrosis (IPF) has resulted in the lack of a gold...
    Sudipto Saha, Sreyashi Majumdar, Parthasarathi Bhattacharyya in Pulmonomics: Omics Approaches for Understanding Pulmonary Diseases
    Chapter 2023
  18. STAT6 promoting oxalate crystal deposition-induced renal fibrosis by mediating macrophage-to-myofibroblast transition via inhibiting fatty acid oxidation

    Objective and design

    Kidney stones commonly occur with a 50% recurrence rate within 5 years, and can elevate the risk of chronic kidney disease....

    Tianhui Yuan, Yuqi **a, ... Fan Cheng in Inflammation Research
    Article 04 November 2023
  19. Engineered extracellular vesicle-encapsulated CHIP as novel nanotherapeutics for treatment of renal fibrosis

    Renal interstitial fibrosis (RIF) is a fundamental pathological feature of chronic kidney disease (CKD). However, toxicity and poor renal enrichment...

    Cheng Ji, Jiahui Zhang, ... Hui Qian in npj Regenerative Medicine
    Article Open access 13 January 2024
Did you find what you were looking for? Share feedback.